DIN 02404761 — GANCICLOVIR FOR INJECTION, USP 500 MG
GANCICLOVIR FOR INJECTION, USP is a powder for solution of Ganciclovir marketed by FRESENIUS KABI CANADA LTD. The full Ganciclovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02404761
- Brand name
- GANCICLOVIR FOR INJECTION, USP
- Active ingredient
- Ganciclovir
- Strength
- 500 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Antiviral agent (synthetic nucleoside analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ganciclovir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02162695 | CYTOVENE | 500 MG | POWDER FOR SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |
| 02530546 | EYEZIRGAN | 0.15 % | GEL | LABORATOIRES THEA | MARKETED |
| 02537168 | GANCICLOVIR FOR INJECTION | 500 MG | POWDER FOR SOLUTION | FORMATIVE PHARMA INC. | MARKETED |
| 02475391 | GANCICLOVIR FOR INJECTION USP | 500 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED |